Related Experiment Video
Updated: Aug 11, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
Stephen B Baylin1, Joyce E Ohm
1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Bunting-Blaustein Cancer Research Building, 1650 Orleans Street, Suite 530, Baltimore, Maryland 21231, USA. sbaylin@JHMI.edu
Abstract:
Chromatin alterations have been associated with all stages of tumour formation and progression. The best characterized are epigenetically mediated transcriptional-silencing events that are associated with increases in DNA methylation - particularly at promoter regions of genes that regulate important cell functions. Recent evidence indicates that epigenetic changes might 'addict' cancer cells to altered signal-transduction pathways during the early stages of tumour development. Dependence on these pathways for cell proliferation or survival allows them to acquire genetic mutations in the same pathways, providing the cell with selective advantages that promote tumour progression. Strategies to reverse epigenetic gene silencing might therefore be useful in cancer prevention and therapy.
Insights
Epigenetic changes, like DNA methylation, can drive cancer development by altering gene expression and creating dependencies on specific cell pathways. Reversing these epigenetic alterations may offer new strategies for cancer prevention and treatment.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Chromatin alterations are hallmarks of cancer development and progression.
- Epigenetically mediated transcriptional silencing, often via DNA methylation, is a key mechanism.
- These epigenetic changes may create dependencies in cancer cells on specific signaling pathways.
Purpose of the Study:
- To explore the role of epigenetic alterations in cancer cell addiction to signaling pathways.
- To investigate the potential of reversing epigenetic gene silencing for cancer therapy.
Main Methods:
- Review of recent evidence on epigenetic changes in tumorigenesis.
- Analysis of the link between epigenetic modifications and genetic mutations in cancer progression.
Main Results:
- Epigenetic changes can 'addict' cancer cells to altered signal-transduction pathways early in tumor development.
- This addiction facilitates the acquisition of genetic mutations, conferring selective advantages.
- Dependence on these pathways is crucial for cancer cell proliferation and survival.
Conclusions:
- Reversing epigenetic gene silencing presents a promising therapeutic strategy.
- Targeting epigenetic modifications could be beneficial for cancer prevention and treatment.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
